Company Announcements

Air Liquide Strengthens Its Home Healthcare Offer With a Major Acquisition in Poland

PARIS--(BUSINESS WIRE)--Oct. 7, 2021-- Regulatory News:

Air Liquide (Paris:AI) is continuing to develop its home healthcare business in Europe with the acquisition of Betamed S.A., a major home healthcare provider in Poland. Betamed specialises in the care of patients with severe pathologies, either at home or in its specialised clinic in Chorzów in Silesia. This acquisition enables the Group to strengthen its presence in Poland and to expand its range of services to support patients suffering from complex forms of chronic diseases.

Founded in 2001 and headed by Beata Drzazga, Betamed S.A. is the Polish leader in home healthcare for patients suffering from severe pathologies, such as respiratory diseases, stroke, heart disease, neuromuscular diseases or paraplegia. The company supports 5,000 patients, and also runs a specialised clinicwith over 100 beds for dependent patients, both adults and children, who require mechanical ventilation.In 2020, Betamed S.A. generated revenue of nearly 25 million euros.

Since 2012, Air Liquide has made several acquisitions in home healthcare in Poland, and is now a recognised player in mechanical ventilation at home, in the country. The acquisition of Betamed S.A. marks a new stage in the development of its home healthcare business in Poland, as it enables the Group to offer its patients a broader, more diversified and complementary range of services across the entire care pathway, through an extended geographical presence. In addition to the expertise of the founder of Betamed S.A., Beata Drzazga, Air Liquide Healthcare will rely on the existing teams to further develop its business.

Diana Schillag , member of the Air Liquide Group’s Executive Committee supervising the Healthcare business line, declared: “We are pleased to welcome to Air Liquide Healthcare the teams of Betamed S.A., recognised for their expertise in the monitoring and care of patients with severe pathologies. This operation will enable the Group to strengthen its offer and its presence in home healthcare in Poland, in line with the strategy that the Group is deploying in the rest of Europe. As a major player in home healthcare, Air Liquide’s ambition is to best meet the needs of patients and healthcare professionals.”

Air Liquide’s Home Healthcare business

Air Liquide, the leading European player in home healthcare, provides prescription care for patients suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary Disease), sleep apnoea, Parkinson’s disease and diabetes. Alongside hospital care, this business is developing in the patient’s home, since it enables better quality of life and a reduction in treatment costs. Home healthcare business represents 50% of Air Liquide’s 2020 Healthcare business revenue.

A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 78 countries with approximately 64,500 employees and serves more than 3.8 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.

 

Air Liquide’s ambition is to be a leader in its industry, deliver long term performance and contribute to sustainability - with a strong commitment to climate change and energy transition at the heart of its strategy. The company’s customer-centric transformation strategy aims at profitable, regular and responsible growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.

 

Air Liquide’s revenue amounted to more than 20 billion euros in 2020. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good indexes.

 

Corporate Communications
media@airliquide.com

Investor Relations
IRTeam@airliquide.com

Source: Air Liquide